Impact of renal function on eligibility for chemotherapy and survival in patients who have undergone radical nephro‐ureterectomy

Évanguelos Xylinas(NewYork–Presbyterian Hospital), Shahrokh F. Shariat(Al-Ahliyya Amman University), Yair Lotan(The University of Texas Southwestern Medical Center), Giacomo Novara(University of Padua), Marc Zerbib(Université Paris Cité), Douglas S. Scherr(NewYork–Presbyterian Hospital), Thomas Clozel(NewYork–Presbyterian Hospital), Francesco Montorsi(Vita-Salute San Raffaele University), Morgan Rouprêt(Sorbonne Université), Michael Rink(Marienkrankenhaus Hamburg), Quoc‐Dien Trinh(Université de Montréal), Evi Comploj(Ospedale di Bolzano), Vitaly Margulis(The University of Texas MD Anderson Cancer Center), Richard K. Lee(NewYork–Presbyterian Hospital), Pierre I. Karakiewicz(Université de Montréal), Armin Pycha(Ospedale di Bolzano), Jay D. Raman(Cornell University), Alon Z. Weizer(University of Michigan), Vincenzo Ficarra(University of Padua), Christian Seitz(Medical University of Vienna)
British Journal of Urology
March 6, 2013
Cited by 165


Related Papers